Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Pharmaceuticals (MIST) Cash from Financing Activities: 2021-2022

Historic Cash from Financing Activities for Milestone Pharmaceuticals (MIST) over the last 2 years, with Dec 2022 value amounting to $227,000.

  • Milestone Pharmaceuticals' Cash from Financing Activities rose 146.74% to $227,000 in Q4 2022 from the same period last year, while for Dec 2022 it was $3.1 million, marking a year-over-year decrease of 38.91%. This contributed to the annual value of $32.1 million for FY2024, which is 32.79% down from last year.
  • According to the latest figures from Q4 2022, Milestone Pharmaceuticals' Cash from Financing Activities is $227,000, which was down 91.50% from $2.7 million recorded in Q3 2022.
  • Over the past 5 years, Milestone Pharmaceuticals' Cash from Financing Activities peaked at $4.9 million during Q2 2021, and registered a low of $19,000 during Q1 2021.
  • In the last 2 years, Milestone Pharmaceuticals' Cash from Financing Activities had a median value of $116,000 in 2021 and averaged $1.0 million.
  • Within the past 5 years, the most significant YoY rise in Milestone Pharmaceuticals' Cash from Financing Activities was 11,033.33% (2022), while the steepest drop was 97.15% (2022).
  • Over the past 2 years, Milestone Pharmaceuticals' Cash from Financing Activities (Quarterly) stood at $92,000 in 2021, then soared by 146.74% to $227,000 in 2022.
  • Its Cash from Financing Activities was $227,000 in Q4 2022, compared to $2.7 million in Q3 2022 and $140,000 in Q2 2022.